|
Well, from what I found online it doesn't look good.
ASXL1 = generally associated with signs of aggressiveness and poor clinical outcome, prognostic biomarker, associated with shorter overall survival
EZH2 = prognostic biomarker, associated with shorter overall survival
PTPN11 = oncogene, potential to cause normal cells to become cancerous
RUNX1 = prognostic biomarker, associated with shorter overall survival
STAG2 = has been associated with less favorable clinical outcomes
TET2 = neutral or favorable prognostic biomarker however shorter overall survival following hematopoietic stem cell transplantation.
__________________
Joanne, 65F, 8/17 dx Primary MDS-EB1, Pancytopenia; 6/19 MPN w/CMML characteristics, dr calling it AML even w/blasts <20%; 7/19 Induction w/Vyxeos resulting in complete remission with incomplete blood count recovery.
|